Related Experiment Videos
Xenotransplantation: a possible solution to the shortage of donor organs
F H Bach1, H Winkler, C J Wrighton
1Sandoz Center for Immunobiology, New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.
Transplantation Proceedings
|February 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Significant lethality following liver resection in A20 heterozygous knockout mice uncovers a key role for A20 in liver regeneration.
Cell death and differentiation·2015
High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue.
Molecular therapy : the journal of the American Society of Gene Therapy·2001
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors.
Molecular therapy : the journal of the American Society of Gene Therapy·2001
Survival of Hepatocellular Carcinoma After Liver Transplantation: Validation of Malatya Criteria.
Transplantation proceedings·2026
Risk Factors for Acute Kidney Injury After Conventional Open Liver Transplantation: A Single-Center Retrospective Cohort Study.
Transplantation proceedings·2026
Influence of Donor Age on Graft and Patient Outcomes in Kidney Transplantation: A Systematic Review and Meta-Analysis.
Transplantation proceedings·2026
Pooled Analysis of Valve-in-Valve and Valve-in-Ring Transcatheter Mitral Valve Replacement Using the SAPIEN Valve.
Journal of the American Heart Association·2026
tRNA‑derived RNAs in hepatic diseases: From biological functions to clinical translation (Review).
International journal of molecular medicine·2026
Carotid stent infection caused by Burkholderia pseudomallei successfully treated with surgery.
Journal of vascular surgery cases and innovative techniques·2026
FP003B suppresses microcarrier aggregation and enhances cell yield in microcarrier-based mesenchymal stromal cell culture.
Frontiers in bioengineering and biotechnology·2026
First-line biologic and targeted synthetic DMARDs versus methotrexate in early rheumatoid arthritis: a meta-analysis of remission outcomes.
Rheumatology (Oxford, England)·2026